Skip to main content

Table 4 Baseline characteristics and parasitological responses in dihydroartemisinin-piperaquine-treated children who participated in evaluation of the comparison of estimates of parasite clearance time derived from linear regression equation and microscopy-determined parasite clearance time

From: Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children

Variables

Initial phase (n = 166)

Later phase (n = 155)

All (n = 321)

P value

Male: Female

90:76

93:62

183:138

0.35

Age (month)

 Mean (95% CI)

37.6 (34.9–40.2)

39.5 (36.9–42)

38.1 (36.4–39.7)

0.31

 No. ≤ 12 months (%)

16 (9.6)

13 (8.4)

29 (9)

0.84

Duration of illness (day)

 Mean (95% CI)

3.8 (3.2–4.4)

4.1 (3.4–4.7)

3.8 (3.4–4.2)

0.53

Weight (kg)

 Mean (95% CI)

12.8 (12.2–13.5)

13.1 (12.5–13.7)

12.9 (12.4–13.3)

0.56

Temperature (°C)

 Mean (95% CI)

37.8 (37.6–38)

37.8 (37.5–38)

37.8 (37.7–37.9)

0.8

No. with

  ≥ 37.5 °C (%)

94 (56.6)

99 (63.9)

193 (60.1)

0.23

  ≥ 40 °C (%)

15 (9)

13 (8.4)

28 (8.7)

0.99

Haematocrit (%)

 Mean (95% CI)

30.6 (29.7–31.5)

31.3 (30.6–32)

30.8 (30.3–31.4)

0.21

 No with anaemia (%)

59 (35.5)

45 (29)

104 (32.4)

0.34

  Mild (%)

48 (28.9)

43 (27.7)

91 (28.3)

0.65

  Moderate (%)

11 (6.6)

2 (1.3)

13 (4)

0.02

  Severe (%)

0 (0)

0 (0)

0 (0)

–

Parasitaemia (/μl)

 Geometric mean (Range)

16 319 (2000–200 000)

14 057 (2003–198 000)

15 185 (2000–200 000)

0.27

 Gametocytaemia (%)

15 (9)

4 (2.6)

19 (5.9)

0.02

Parasite positivity

 On day 1

87

83

170

0.93

 On day 2

29

31

60

0.66

 On day 3

5

2

7

0.45

Parasite clearance time (day)

 Mean (95% CI)

1.8 (1.6–1.9)

1.8 (1.7–1.9)

1.8 (1.7–1.9)

0.88

PRRD1

 Geometric mean (95% CI)

923 (585–1456)

695 (421–1149)

805 (574–1129)

0.46

PRRD2

 Geometric mean (95% CI)

7428 (5298–10 415)

5143 (3407–7765)

6220 (4772–8108)

0.3

  1. PRRD1 Parasite reduction ratio 1 day after treatment initiation, PRRD2 Parasite reduction ratio 2 days after treatment initiation, CI Confidence interval